Prot #R668-AD-2217: An Open-Label Single-Arm Study of Dupilumab in Adolescent and Adult Skin of Color Patients with Moderate-to-Severe Atopic Dermatitis

Project: Research project

Project Details

StatusActive
Effective start/end date10/26/2310/26/26

Funding

  • Parexel (Prot # R668-AD-2217 // Prot # R668-AD-2217)
  • Regeneron Pharmaceuticals, Inc. (Prot # R668-AD-2217 // Prot # R668-AD-2217)